mAb Name,Target,Therapeutic Area,PDB ID
Adalimumab,TNF-alpha,Immunology (Rheumatoid arthritis, Crohn's disease),1hje
Infliximab,TNF-alpha,Immunology (Rheumatoid arthritis, Crohn's disease),1n8t
Etanercept,TNF-alpha,Immunology (Rheumatoid arthritis, Crohn's disease),2gs7
Rituximab,CD20,Immunology (Non-Hodgkin lymphoma, rheumatoid arthritis),1fvd
Trastuzumab,HER2,Oncology (Breast cancer),1n8z
Bevacizumab,VEGF,Oncology (Colorectal cancer, lung cancer),1bj1
Cetuximab,EGFR,Oncology (Colorectal cancer, head and neck cancer),1yy9
Panitumumab,EGFR,Oncology (Colorectal cancer),3m0e
Ustekinumab,IL-12/IL-23,Immunology (Psoriasis, Crohn's disease),4kzv
Omalizumab,IgE,Immunology (Asthma, chronic urticaria),1ia0
Palivizumab,RSV F protein,Infectious Diseases (Respiratory syncytial virus),1qgv
Natalizumab,alpha4-integrin,Immunology (Multiple sclerosis, Crohn's disease),3o8v
Vedolizumab,alpha4beta7 integrin,Immunology (Ulcerative colitis, Crohn's disease),5lnz
Alemtuzumab,CD52,Immunology (Chronic lymphocytic leukemia, multiple sclerosis),N/A
Ofatumumab,CD20,Immunology (Chronic lymphocytic leukemia),3g6x
Ipilimumab,CTLA-4,Oncology (Melanoma),3osl
Nivolumab,PD-1,Oncology (Lung cancer, melanoma),5dk3
Pembrolizumab,PD-1,Oncology (Lung cancer, melanoma),5jxr
Atezolizumab,PD-L1,Oncology (Urothelial cancer, lung cancer),5x8j
Avelumab,PD-L1,Oncology (Merkel cell carcinoma, bladder cancer),5w2x
Durvalumab,PD-L1,Oncology (Lung cancer, bladder cancer),5jgv
Eculizumab,C5,Hematology (Paroxysmal nocturnal hemoglobinuria),4ll8
Denosumab,RANKL,Osteoporosis,3w92
Secukinumab,IL-17A,Immunology (Psoriasis, ankylosing spondylitis),4hr6
Ixekizumab,IL-17A,Immunology (Psoriasis),4kzz
Brodalumab,IL-17 receptor,Immunology (Psoriasis),5l6i
Guselkumab,IL-23,Immunology (Psoriasis),N/A
Tildrakizumab,IL-23,Immunology (Psoriasis),N/A
Risankizumab,IL-23,Immunology (Psoriasis),6dkf
Bimekizumab,IL-17A/F,Immunology (Psoriasis),N/A
Dupilumab,IL-4R alpha,Immunology (Atopic dermatitis, asthma),5ung
Mepolizumab,IL-5,Immunology (Eosinophilic asthma),5lkq
Reslizumab,IL-5,Immunology (Eosinophilic asthma),4n8u
Benralizumab,IL-5 receptor,Immunology (Eosinophilic asthma),5n6f
Ocrelizumab,CD20,Immunology (Multiple sclerosis),5v5o
Golimumab,TNF-alpha,Immunology (Rheumatoid arthritis, ankylosing spondylitis),3tn9
Certolizumab pegol,TNF-alpha,Immunology (Rheumatoid arthritis, Crohn's disease),3sdy
Canakinumab,IL-1 beta,Immunology (Cryopyrin-associated periodic syndromes),2n0i
Evolocumab,PCSK9,Cardiology (Hypercholesterolemia),3g5o
Alirocumab,PCSK9,Cardiology (Hypercholesterolemia),4uyp
Belimumab,BAFF,Immunology (Systemic lupus erythematosus),3kml
Daratumumab,CD38,Oncology (Multiple myeloma),5f1t
Elotuzumab,SLAMF7,Oncology (Multiple myeloma),4hje
Brentuximab vedotin,CD30,Oncology (Hodgkin lymphoma, anaplastic large cell lymphoma),4n9m
Ramucirumab,VEGFR2,Oncology (Gastric cancer, colorectal cancer),4t92
Pertuzumab,HER2,Oncology (Breast cancer),1s78
Obinutuzumab,CD20,Immunology (Chronic lymphocytic leukemia),4z00
Ibritumomab tiuxetan,CD20,Oncology (Non-Hodgkin lymphoma),N/A
Tositumomab,CD20,Oncology (Non-Hodgkin lymphoma),N/A
Afelimomab,Tumor Necrosis Factor-alpha,Sepsis,1tnf
Anatumomab mafenatox,TAG-72,Colorectal cancer,2q8f
Anrukinzumab,Interleukin-13,Asthma,4j67
Arcitumomab,Carcinoembryonic Antigen (CEA),Colorectal cancer,1eaj
Bapineuzumab,Amyloid beta,Alzheimer's disease,3d6e
Bavituximab,Phosphatidylserine,Oncology,2dpg
Benralizumab,Interleukin-5 Receptor Subunit Alpha (IL5RA),Eosinophilic Asthma,4x9w
Bermekimab,Interleukin-1 alpha,Autoinflammatory diseases,4dep
Bimagrumab,Activin receptor type II,Muscular dystrophy,4jau
Blosozumab,Sclerostin,Osteoporosis,4a6s
Brodalumab,IL-17 Receptor A,Psoriasis,5l6i
Caplacizumab,von Willebrand Factor (vWF),Acquired Thrombotic Thrombocytopenic Purpura,6x9i
Cixutumumab,Insulin-like Growth Factor 1 Receptor (IGF-1R),Solid tumors,3f5p
Clazakizumab,Interleukin-6,Rheumatoid arthritis,5v7i
Crenezumab,Amyloid beta,Alzheimer's disease,5vji
Dinutuximab,GD2 ganglioside,Neuroblastoma,3v7e
Dostarlimab,PD-1,Endometrial cancer,6v68
Duligotumab,IL-33,Asthma,4kcw
Efalizumab,LFA-1,Psoriasis,1lfa
Eldelumab,SLAMF7,Multiple myeloma,4h2q
Enavatuzumab,Delta-like protein 3,Small-cell lung cancer,5imq
Enfortumab vedotin,Nectin-4,Urothelial carcinoma,6ii8
Ertumaxomab,HER2/CD3,Gastric cancer,3h0t
Fasinumab,NGF,Osteoarthritis,3j72
Fontolizumab,Interferon gamma,Multiple sclerosis,1fg9
Fresolimumab,TGF-beta,Renal Transplant Rejection,2pjy
Galcanezumab,CGRP,Migraine,6w1o
Ganitumab,IGF-1R,Various cancers,3lvp
Ianalumab,Blood coagulation factor VIII,Hemophilia A,6csq
Ibritumomab tiuxetan,CD20,Non-Hodgkin lymphoma,1i9w
Imciromab,GPIIb/IIIa,Thrombosis,1ty3
Imlifidase,IdeS enzyme,Kidney Transplantation,6t4n
Inebilizumab,CD19,Neuromyelitis optica spectrum disorder,6bxo
Inolimomab,CD25,Graft-versus-host disease (GVHD),2erj
Lebrikizumab,IL-13,Asthma,4j67
Lemalesomab,TNFSF14,Melanoma,4jio
Lerdelimumab,TNF-alpha,Crohn's disease,1tnf
Lorvotuzumab mertansine,CD56,Small cell lung cancer,5jpy
Mepolizumab,IL-5,Eosinophilic asthma,5lkq
Moxetumomab pasudotox,CD22,Hairy cell leukemia,3toh
Natalizumab,Integrin alpha4,Multiple sclerosis,3o8v
Necitumumab,EGFR,Lung cancer,3njp
Nimotuzumab,EGFR,Head and neck cancer,3lzf
Odulimomab,LFA-3,Organ transplant rejection,1l6z
Otelixizumab,CD3,Type 1 diabetes,3h3v
Pagibaximab,Botulinum neurotoxin serotype A,Infant botulism,3dvx
Panitumumab,EGFR,Colorectal cancer,3moe
Parsatuzumab,HER2,Breast cancer,4hr7
Pateclizumab,RSV F protein,Respiratory syncytial virus,2xrl
Ramucirumab,VEGFR2,Gastric cancer,4t92
Raxibacumab,Protective antigen,Anthrax,3kwv
Abituzumab,CD33,Acute myeloid leukemia (AML),1t8h
Actoxumab,C. difficile toxin A,Clostridium difficile infection,5ile
Afelimomab,Tumor necrosis factor-alpha,Sepsis,1tnf
Anakinra,IL-1 receptor antagonist,Rheumatoid arthritis,1y2q
Anrukinzumab,IL-13,Asthma,4j67
Bapineuzumab,Amyloid beta,Alzheimer's disease,3d6e
Bavituximab,Phosphatidylserine,Oncology,2dpg
Benralizumab,IL-5Rα,Eosinophilic asthma,4x9w
Bevacizumab,VEGF,Various cancers,1bj1
Bezlotoxumab,C. difficile toxin B,Clostridium difficile infection,5inu
Bimekizumab,IL-17A/IL-17F,Psoriasis,7euv
Blinatumomab,CD19/CD3,B-cell acute lymphoblastic leukemia,4n8t
Bococizumab,PCSK9,Hypercholesterolemia,4yqt
Brentuximab Vedotin,CD30,Hodgkin lymphoma,4n9m
Brodalumab,IL-17RA,Psoriasis,5l6i
Camidanlumab,PD-1,Melanoma,5ggs
Cantuzumab mertansine,CanAg,Colorectal cancer,1xgt
Caplacizumab,vWF,Acquired thrombotic thrombocytopenic purpura,6x9i
Certolizumab pegol,TNF-alpha,Crohn's disease, Rheumatoid arthritis,3sdy
Cixutumumab,IGF-1 receptor,Solid tumors,3f5p
Clazakizumab,IL-6,Rheumatoid arthritis,5v7i
Conatumumab,TRAIL-R2,Various cancers,3i9k
Crizanlizumab,P-selectin,Vaso-occlusive crisis,5ktk
Denosumab,RANKL,Osteoporosis,3w92
Dinutuximab,GD2 ganglioside,Neuroblastoma,3v7e
Dostarlimab,PD-1,Endometrial cancer,6v68
Duligotumab,IL-33,Asthma,4kcw
Eculizumab,Complement C5,Paroxysmal nocturnal hemoglobinuria,4ll8
Efalizumab,LFA-1,Psoriasis,1lfa
Eldelumab,SLAMF7,Multiple myeloma,4h2q
Elotuzumab,SLAMF7,Multiple myeloma,4hje
Emibetuzumab,ErbB3,Solid tumors,7ce5
Enavatuzumab,DLL3,Small-cell lung cancer,5imq
Erenumab,CGRP receptor,Migraine,6bey
Farletuzumab,Folate receptor 1,Ovarian cancer,2xfj
Faricimab,Ang-2/VEGF-A,Diabetic macular edema,7vu7
Fasinumab,NGF,Osteoarthritis,3j72
Fontolizumab,Interferon gamma,Multiple sclerosis,1fg9
Galcanezumab,CGRP,Migraine,6w1o
Ganitumab,IGF-1R,Various cancers,3lvp
Gemtuzumab ozogamicin,CD33,Acute myeloid leukemia,1qgh
Abrilumab,IL-13Rα2,Asthma,4grg
Alicamab,CEA,Colorectal cancer,2qce
Anrukinzumab,IL-13,Asthma,4j67
Arcitumomab,Carcinoembryonic antigen (CEA),Colorectal cancer,1eaj
Bapineuzumab,Amyloid beta,Alzheimer's disease,3d6e
Bavituximab,Phosphatidylserine,Oncology,2dpg
Benralizumab,IL-5Rα,Eosinophilic asthma,4x9w
Bevacizumab,VEGF,Various cancers,1bj1
Bezlotoxumab,C. difficile toxin B,Clostridium difficile infection,5inu
Bimekizumab,IL-17A/IL-17F,Psoriasis,7euv
Bococizumab,PCSK9,Hypercholesterolemia,4yqt
Brodalumab,IL-17RA,Psoriasis,5l6i
Camidanlumab,PD-1,Melanoma,5ggs
Caplacizumab,vWF,Acquired thrombotic thrombocytopenic purpura,6x9i
Cixutumumab,IGF-1 receptor,Solid tumors,3f5p
Clazakizumab,IL-6,Rheumatoid arthritis,5v7i
Conatumumab,TRAIL-R2,Various cancers,3i9k
Crizanlizumab,P-selectin,Vaso-occlusive crisis,5ktk
Denosumab,RANKL,Osteoporosis,3w92
Dinutuximab,GD2 ganglioside,Neuroblastoma,3v7e
Ecluzimab,Complement C5,Paroxysmal nocturnal hemoglobinuria,4ll8
Efalizumab,LFA-1,Immunology (Psoriasis),1lfa
Elotuzumab,SLAMF7,Oncology (Multiple myeloma),4hje
Enavatuzumab,DLL3,Small-cell lung cancer,5imq
Ertumaxomab,HER2/CD3,Oncology (Gastric cancer),3h0t
Fasinumab,NGF,Pain (Osteoarthritis),3j72
Fontolizumab,Interferon gamma,Multiple sclerosis,1fg9
Galcanezumab,CGRP,Migraine,6w1o
Ganitumab,IGF-1R,Oncology (Various cancers),3lvp
Gemtuzumab ozogamicin,CD33,Oncology (Acute myeloid leukemia),1qgh
Ianalumab,Blood coagulation factor VIII,Hemophilia A,6csq
Ibritumomab tiuxetan,CD20,Non-Hodgkin lymphoma,1i9w
Imciromab,GPIIb/IIIa,Thrombosis,1ty3
Inebilizumab,CD19,Neuromyelitis optica spectrum disorder,6bxo
Inotuzumab ozogamicin,CD22,Oncology (Acute lymphoblastic leukemia),3g9w
Ixekizumab,IL-17A,Psoriasis,4kzz
Lebrikizumab,IL-13,Asthma,4j67
Lemalesomab,TNFSF14,Melanoma,4jio
Lerdelimumab,TNF-alpha,Crohn's disease,1tnf
Mepolizumab,IL-5,Immunology (Eosinophilic asthma),5lkq
Mogamulizumab,CCR4,Oncology (Cutaneous T-cell lymphoma),3wip
Moxetumomab pasudotox,CD22,Hairy cell leukemia,3toh
Natalizumab,Integrin alpha-4,Multiple Sclerosis, Crohn's Disease,3o8v
Necitumumab,EGFR,Squamous Non-Small Cell Lung Cancer (NSCLC),3njp
Nivolumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5wt9
Ocrelizumab,CD20,Multiple Sclerosis,5v5o
Odulimomab,Lymphocyte function-associated antigen 3 (LFA-3),Organ Transplant Rejection,1l6z
Ofatumumab,CD20,Chronic Lymphocytic Leukemia,3g6x
Omalizumab,IgE,Allergic Asthma, Chronic Idiopathic Urticaria,1iao
Otelixizumab,CD3,Type 1 Diabetes,3h3v
Pagibaximab,Botulinum neurotoxin serotype A,Infant Botulism,3dvx
Panitumumab,Epidermal Growth Factor Receptor (EGFR),Colorectal Cancer,3moe
Parsatuzumab,HER2,Breast Cancer,4hr7
Pateclizumab,Respiratory Syncytial Virus Fusion Protein (RSV F),Respiratory Syncytial Virus (RSV),2xrl
Pembrolizumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5jxr
Ramucirumab,Vascular Endothelial Growth Factor Receptor 2 (VEGFR2),Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC),4t92
Raxibacumab,Protective Antigen (PA),Anthrax,3kwv
Reslizumab,Interleukin 5 (IL5),Eosinophilic Asthma,4n8u
Risankizumab,Interleukin 23 (IL23),Plaque Psoriasis,6dkf
Rituximab,CD20,Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia,1fvd
Actoxumab,C. difficile toxin A,Infectious Diseases,5ile
Adnectumab,DLL4,Oncology (Solid tumors),5l81
Afucosylated Anti-B Blood Group IgG,ABO blood group antigen B,Immunology (ABO-incompatible kidney transplantation),5v85
Alicamab,CEA,Oncology (Colorectal cancer),2qce
Aselizumab,L-selectin,Immunology (Asthma, psoriasis),1gc5
Bapineuzumab,Amyloid beta,Neurology (Alzheimer's disease),3d6e
Belimumab,BAFF,Immunology (Systemic lupus erythematosus),3kml
Benralizumab,IL-5 receptor alpha subunit,Asthma,5n6f
Bermekimab,IL-1alpha,Autoinflammatory diseases,4dep
Bezlotoxumab,C. difficile toxin B,Infectious Diseases (C. difficile infection),5inu
Bimagrumab,Activin receptor type II,Muscular dystrophy,4jau
Blosozumab,Sclerostin,Osteoporosis,4a6s
Brodalumab,IL-17RA,Psoriasis,5l6i
Camidanlumab,PD-1,Oncology (Melanoma),5ggs
Certolizumab pegol,TNF-alpha,Crohn's disease, Rheumatoid arthritis,3sdy
Cixutumumab,IGF-1 receptor,Oncology (Solid tumors),3f5p
Clazakizumab,IL-6,Rheumatoid arthritis,5v7i
Conatumumab,TRAIL-R2,Oncology (Various cancers),3i9k
Crenezumab,Amyloid beta,Alzheimer's disease,5vji
Denosumab,RANKL,Osteoporosis,3w92
Dostarlimab,PD-1,Endometrial cancer,6v68
Duligotumab,IL-33,Asthma,4kcw
Ecluzimab,Complement C5,Paroxysmal nocturnal hemoglobinuria,4ll8
Efalizumab,LFA-1,Immunology (Psoriasis),1lfa
Elotuzumab,SLAMF7,Oncology (Multiple myeloma),4hje
Emibetuzumab,ErbB3,Oncology (Solid tumors),7ce5
Enfortumab vedotin,Nectin-4,Urothelial carcinoma,6ii8
Ertumaxomab,HER2/CD3,Oncology (Gastric cancer),3h0t
Fasinumab,NGF,Pain (Osteoarthritis),3j72
Fontolizumab,Interferon gamma,Multiple sclerosis,1fg9
Galcanezumab,CGRP,Migraine,6w1o
Ganitumab,IGF-1R,Oncology (Various cancers),3lvp
Gemtuzumab ozogamicin,CD33,Oncology (Acute myeloid leukemia),1qgh
Ianalumab,Blood coagulation factor VIII,Hemophilia A,6csq
Ibritumomab tiuxetan,CD20,Non-Hodgkin lymphoma,1i9w
Imciromab,GPIIb/IIIa,Thrombosis,1ty3
Inebilizumab,CD19,Neuromyelitis optica spectrum disorder,6bxo
Inotuzumab ozogamicin,CD22,Oncology (Acute lymphoblastic leukemia),3g9w
Ixekizumab,IL-17A,Psoriasis,4kzz
Lebrikizumab,IL-13,Asthma,4j67
Lemalesomab,TNFSF14,Melanoma,4jio
Lerdelimumab,TNF-alpha,Crohn's disease,1tnf
Mepolizumab,IL-5,Immunology (Eosinophilic asthma),5lkq
Mogamulizumab,CCR4,Oncology (Cutaneous T-cell lymphoma),3wip
Moxetumomab pasudotox,CD22,Hairy cell leukemia,3toh
Natalizumab,Integrin alpha-4,Multiple Sclerosis, Crohn's Disease,3o8v
Necitumumab,EGFR,Squamous Non-Small Cell Lung Cancer (NSCLC),3njp
Nivolumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5wt9
Ocrelizumab,CD20,Multiple Sclerosis,5v5o
Odulimomab,Lymphocyte function-associated antigen 3 (LFA-3),Organ Transplant Rejection,1l6z
Ofatumumab,CD20,Chronic Lymphocytic Leukemia,3g6x
Omalizumab,IgE,Allergic Asthma, Chronic Idiopathic Urticaria,1iao
Otelixizumab,CD3,Type 1 Diabetes,3h3v
Pagibaximab,Botulinum neurotoxin serotype A,Infant Botulism,3dvx
Panitumumab,Epidermal Growth Factor Receptor (EGFR),Colorectal Cancer,3moe
Parsatuzumab,HER2,Breast Cancer,4hr7
Pateclizumab,Respiratory Syncytial Virus Fusion Protein (RSV F),Respiratory Syncytial Virus (RSV),2xrl
Pembrolizumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5jxr
Ramucirumab,Vascular Endothelial Growth Factor Receptor 2 (VEGFR2),Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC),4t92
Raxibacumab,Protective Antigen (PA),Anthrax,3kwv
Reslizumab,Interleukin 5 (IL5),Eosinophilic Asthma,4n8u
Risankizumab,Interleukin 23 (IL23),Plaque Psoriasis,6dkf
Rituximab,CD20,Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia,1fvd
Actoxumab,C. difficile toxin A,Infectious Diseases,5ile
Adnectumab,DLL4,Oncology (Solid tumors),5l81
Afucosylated Anti-B Blood Group IgG,ABO blood group antigen B,Immunology (ABO-incompatible kidney transplantation),5v85
Alicamab,CEA,Oncology (Colorectal cancer),2qce
Aselizumab,L-selectin,Immunology (Asthma, psoriasis),1gc5
Bapineuzumab,Amyloid beta,Neurology (Alzheimer's disease),3d6e
Belimumab,BAFF,Immunology (Systemic lupus erythematosus),3kml
Benralizumab,IL-5 receptor alpha subunit,Asthma,5n6f
Bermekimab,IL-1alpha,Autoinflammatory diseases,4dep
Bezlotoxumab,C. difficile toxin B,Infectious Diseases (C. difficile infection),5inu
Bimagrumab,Activin receptor type II,Muscular dystrophy,4jau
Blosozumab,Sclerostin,Osteoporosis,4a6s
Brodalumab,IL-17RA,Psoriasis,5l6i
Camidanlumab,PD-1,Oncology (Melanoma),5ggs
Certolizumab pegol,TNF-alpha,Crohn's disease, Rheumatoid arthritis,3sdy
Cixutumumab,IGF-1 receptor,Oncology (Solid tumors),3f5p
Clazakizumab,IL-6,Rheumatoid arthritis,5v7i
Conatumumab,TRAIL-R2,Oncology (Various cancers),3i9k
Crenezumab,Amyloid beta,Alzheimer's disease,5vji
Denosumab,RANKL,Osteoporosis,3w92
Dostarlimab,PD-1,Endometrial cancer,6v68
Duligotumab,IL-33,Asthma,4kcw
Ecluzimab,Complement C5,Paroxysmal nocturnal hemoglobinuria,4ll8
Efalizumab,LFA-1,Immunology (Psoriasis),1lfa
Elotuzumab,SLAMF7,Oncology (Multiple myeloma),4hje
Emibetuzumab,ErbB3,Oncology (Solid tumors),7ce5
Enfortumab vedotin,Nectin-4,Urothelial carcinoma,6ii8
Ertumaxomab,HER2/CD3,Oncology (Gastric cancer),3h0t
Fasinumab,NGF,Pain (Osteoarthritis),3j72
Fontolizumab,Interferon gamma,Multiple sclerosis,1fg9
Galcanezumab,CGRP,Migraine,6w1o
Ganitumab,IGF-1R,Oncology (Various cancers),3lvp
Gemtuzumab ozogamicin,CD33,Oncology (Acute myeloid leukemia),1qgh
Ianalumab,Blood coagulation factor VIII,Hemophilia A,6csq
Ibritumomab tiuxetan,CD20,Non-Hodgkin lymphoma,1i9w
Imciromab,GPIIb/IIIa,Thrombosis,1ty3
Inebilizumab,CD19,Neuromyelitis optica spectrum disorder,6bxo
Inotuzumab ozogamicin,CD22,Oncology (Acute lymphoblastic leukemia),3g9w
Ixekizumab,IL-17A,Psoriasis,4kzz
Lebrikizumab,IL-13,Asthma,4j67
Lemalesomab,TNFSF14,Melanoma,4jio
Lerdelimumab,TNF-alpha,Crohn's disease,1tnf
Mepolizumab,IL-5,Immunology (Eosinophilic asthma),5lkq
Mogamulizumab,CCR4,Oncology (Cutaneous T-cell lymphoma),3wip
Moxetumomab pasudotox,CD22,Hairy cell leukemia,3toh
Natalizumab,Integrin alpha-4,Multiple Sclerosis, Crohn's Disease,3o8v
Necitumumab,EGFR,Squamous Non-Small Cell Lung Cancer (NSCLC),3njp
Nivolumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5wt9
Ocrelizumab,CD20,Multiple Sclerosis,5v5o
Odulimomab,Lymphocyte function-associated antigen 3 (LFA-3),Organ Transplant Rejection,1l6z
Ofatumumab,CD20,Chronic Lymphocytic Leukemia,3g6x
Omalizumab,IgE,Allergic Asthma, Chronic Idiopathic Urticaria,1iao
Otelixizumab,CD3,Type 1 Diabetes,3h3v
Pagibaximab,Botulinum neurotoxin serotype A,Infant Botulism,3dvx
Panitumumab,Epidermal Growth Factor Receptor (EGFR),Colorectal Cancer,3moe
Parsatuzumab,HER2,Breast Cancer,4hr7
Pateclizumab,Respiratory Syncytial Virus Fusion Protein (RSV F),Respiratory Syncytial Virus (RSV),2xrl
Pembrolizumab,Programmed Cell Death Protein 1 (PD-1),Melanoma, Lung Cancer,5jxr
Ramucirumab,Vascular Endothelial Growth Factor Receptor 2 (VEGFR2),Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC),4t92
Raxibacumab,Protective Antigen (PA),Anthrax,3kwv
Reslizumab,Interleukin 5 (IL5),Eosinophilic Asthma,4n8u
Risankizumab,Interleukin 23 (IL23),Plaque Psoriasis,6dkf
Rituximab,CD20,Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia,1fvd
Belimumab	BAFF	Systemic lupus erythematosus	3KML
Benralizumab	IL-5 receptor alpha subunit	Eosinophilic asthma	5N6F
Bevacizumab	VEGF-A	Colorectal, lung, ovarian, and other cancers	1BJ1
Bezlotoxumab	C. difficile toxin B	Clostridium difficile infection	5INU
Bimekizumab	IL-17A/IL-17F	Psoriasis	7EUV
Brolucizumab	VEGF-A	Age-related macular degeneration (AMD)	6XWO
Canakinumab	IL-1 beta	Autoinflammatory diseases	2N0I
Caplacizumab	vWF	Acquired thrombotic thrombocytopenic purpura	6X9I
Certolizumab pegol	TNF-alpha	Crohn's disease, rheumatoid arthritis	3SDY
Cixutumumab	IGF-1 receptor	Solid tumors	3F5P
Clazakizumab	IL-6	Rheumatoid arthritis	5V7I
Concizumab	Tissue factor pathway inhibitor	Hemophilia	6V61
Crenezumab	Amyloid beta	Alzheimer's disease	5VJI
Eculizumab	Complement component 5	Paroxysmal nocturnal hemoglobinuria (PNH)	4LL8
Efgartigimod	Neonatal Fc receptor (FcRn)	Myasthenia gravis	6RM8
Eldelumab	SLAMF7	Multiple myeloma	4H2Q
Emapalumab	IFN-gamma	Primary HLH	5WUU
Enfortumab vedotin	Nectin-4	Urothelial carcinoma	6II8
Fasinumab	NGF	Osteoarthritis	3J72
Faricimab	Ang-2/VEGF-A	Diabetic macular edema, wet AMD	7VU7
Fontolizumab	IFN-gamma	Multiple sclerosis	1FG9
Fremanezumab	CGRP	Migraine	6UVS
Galcanezumab	CGRP	Migraine	6W1O
Gantenerumab	Amyloid beta	Alzheimer's disease	5WUT
Gemtuzumab ozogamicin	CD33	Acute myeloid leukemia (AML)	1QGH
Ianalumab	Factor VIII	Hemophilia A	6CSQ
Imlifidase	IdeS enzyme	Kidney transplantation	6T4N
Inebilizumab	CD19	Neuromyelitis optica spectrum disorder	6BXO
Inotuzumab ozogamicin	CD22	Acute lymphoblastic leukemia	3G9W
Lebrikizumab	IL-13	Asthma	4J67
Lemalesomab	TNFSF14	Melanoma	4JIO
Ligelizumab	IgE Fc	Chronic spontaneous urticaria	6H3L
Locvotuzumab mertansine	CD56	Small cell lung cancer	5JPY
Mepolizumab	IL-5	Eosinophilic asthma	5LKQ
Moxetumomab pasudotox	CD22	Hairy cell leukemia	3TOH
Natalizumab	Integrin alpha4	Multiple sclerosis	3O8V
Nimotuzumab	EGFR	Head and neck cancer	3LZF
Odulimomab	LFA-3	Organ transplant rejection	1L6Z
Otelixizumab	CD3	Type 1 diabetes	3H3V
Parsatuzumab	HER2	Breast cancer	4HR7
Pateclizumab	RSV F protein	Respiratory syncytial virus	2XRL
Pembrolizumab	PD-1	Melanoma, lung cancer	5JXR
Polatuzumab vedotin	CD79b	Diffuse large B-cell lymphoma	6TCV
Ramucirumab	VEGFR2	Gastric cancer	4T92
Raxibacumab	Protective antigen	Anthrax	3KWV
Reslizumab	IL-5	Eosinophilic asthma	4N8U
Risankizumab	IL-23	Plaque psoriasis	6DKF
Satralizumab	IL-6 receptor	Neuromyelitis optica	6BDI
Sutimlimab	Complement C1s	Cold agglutinin disease	7N7S
Abrilumab	IL-13 receptor subunit alpha-2	Asthma	4GRG
Adalimumab	TNF-alpha	Rheumatoid Arthritis, Crohn's Disease, etc.	1HJE
Aflibercept	VEGF-A/B/PlGF	Age-Related Macular Degeneration (AMD)	N/A (Complex structure, no single PDB entry)
ALEMtuzumab	CD52	Chronic Lymphocytic Leukemia	N/A (No structure available)
Aselizumab	L-selectin	Asthma, Psoriasis	1GC5
Basiliximab	IL-2 receptor	Kidney Transplant Rejection	1ZLJ
Belimumab-lupus	sFLT1	Systemic Lupus Erythematosus (SLE)	6V11
Benralizumab	IL-5 Receptor Alpha	Eosinophilic Asthma	4X9W
Bevacizumab	VEGF-A	Colorectal, Lung, Ovarian, and other Cancers	1BJ1
Bimagrumab	Activin receptor type II	Muscular Dystrophy	4JAU
Blisibimod	BAFF	Systemic Lupus Erythematosus (SLE)	N/A (No structure available)
Bococizumab	PCSK9	Hypercholesterolemia	4YQT
Brentuximab Vedotin	CD30	Hodgkin Lymphoma	4N9M
Briakinumab	IL-12/IL-23	Plaque Psoriasis	4M7D
Canakinumab	IL-1 beta	Autoinflammatory Diseases	2N0I
Certolizumab pegol	TNF-alpha	Crohn's Disease, Rheumatoid Arthritis	3SDY
Cixutumumab	IGF-1 receptor	Solid Tumors	3F5P
Clazakizumab	IL-6	Rheumatoid Arthritis	5V7I
Concizumab	Tissue factor pathway inhibitor	Hemophilia	6V61
Denosumab	RANKL	Osteoporosis	3W92
Dupilumab	IL-4R alpha	Atopic Dermatitis	5UNG
Efalizumab	LFA-1	Psoriasis	1LFA
Eldelumab	SLAMF7	Multiple Myeloma	4H2Q
Emapalumab	IFN-gamma	Primary HLH	5WUU
Enfortumab vedotin	Nectin-4	Urothelial Carcinoma	6II8
Ertumaxomab	HER2/CD3	Gastric Cancer	3H0T
Evolocumab	PCSK9	Hypercholesterolemia	3G5O
Fasinumab	NGF	Osteoarthritis	3J72
Fontolizumab	IFN-gamma	Multiple Sclerosis	1FG9
Fremanezumab	CGRP	Migraine	6UVS
Galcanezumab	CGRP	Migraine	6W1O
Gantenerumab	Amyloid beta	Alzheimer's Disease	5WUT
Guselkumab	IL-23	Plaque Psoriasis	5VV9
Ianalumab	Factor VIII	Hemophilia A	6CSQ
Imlifidase	IdeS enzyme	Kidney Transplantation	6T4N
Inebilizumab	CD19	Neuromyelitis Optica Spectrum Disorder	6BXO
Inolimomab	CD25	Graft-versus-Host Disease (GVHD)	2ERJ
Lebrikizumab	IL-13	Asthma	4J67
Lemalesomab	TNFSF14	Melanoma	4JIO
Ligelizumab	IgE Fc	Chronic Spontaneous Urticaria	6H3L
Locvotuzumab mertansine	CD56	Small Cell Lung Cancer (SCLC)	5JPY
Mepolizumab	IL-5	Eosinophilic Granulomatosis with Polyangiitis (EGPA)	5LKQ
Ibalizumab	CD4	HIV Infection	4UT2	Ibalizumab in complex with CD4 D1 domain
Ixekizumab	IL-17A	Psoriasis	4G6J	Ixekizumab Fab in complex with IL-17A
Lebrikizumab	IL-13	Asthma	3S43	Lebrikizumab Fab in complex with IL-13
Leronlimab	CCR5	HIV Infection, Cancer	4MBS	CCR5 structure, target of Leronlimab
Lifitegrast	LFA-1	Dry Eye Disease	3BQQ	Lifitegrast Fab in complex with LFA-1
Locustavumab	Ang-2	Age-Related Macular Degeneration (AMD)	6YOW	Locustavumab Fab in complex with Ang-2
Luspatercept	Activin receptor IIB	Anemia	6L9D	Luspatercept in complex with ActRIIB
Magrolimab	CD47	Blood Cancers	6OWT	Magrolimab Fab in complex with CD47
Marstacimab	Tissue Factor	COVID-19	1DAN	Tissue Factor structure, target of Marstacimab
Maslimomab	OX40L	Cancer Immunotherapy	1ZR4	OX40 structure, related to OX40L
Mavrilimumab	GM-CSF	Rheumatoid Arthritis	2GMF	GM-CSF structure, target of Mavrilimumab
Mepolizumab	IL-5	Asthma	3B2K	Mepolizumab Fab in complex with IL-5
Mogamulizumab	CCR4	Cutaneous T-cell Lymphoma	3QWO	Mogamulizumab Fab in complex with CCR4
Motavizumab	RSV F protein	Respiratory Syncytial Virus (RSV)	4JHW	Motavizumab Fab in complex with RSV F
Muromonab-CD3	CD3	Organ Transplant Rejection	1K2S	Muromonab-CD3 Fab in complex with CD3
Naptumomab estafenatox	5T4	Colorectal Cancer	2AGM	Naptumomab Fab in complex with 5T4
Natalizumab	α4-Integrin	Multiple Sclerosis	1LFA	Natalizumab Fab in complex with α4β1 integrin
Necitumumab	EGFR	Squamous Non-Small Cell Lung Cancer	3XDT	Necitumumab Fab in complex with EGFR
Nemvaleukin alfa	IL-2	Melanoma	1M47	IL-2 structure, target of Nemvaleukin
Neratinib	HER2	Breast Cancer	3W2S	Neratinib in complex with HER2 kinase
Nimotuzumab	EGFR	Head and Neck Cancer	1YY9	Nimotuzumab Fab in complex with EGFR
Nivolumab	PD-1	Various Cancers	5WT9	Nivolumab in complex with PD-1
Obinutuzumab	CD20	Chronic Lymphocytic Leukemia	3ZVK	Obinutuzumab Fab in complex with CD20
Ocrelizumab	CD20	Multiple Sclerosis	1HYT	Rituximab (similar to Ocrelizumab) Fab complex with CD20
Ofatumumab	CD20	Chronic Lymphocytic Leukemia	3G6W	Ofatumumab Fab in complex with CD20
Olaratumab	PDGFRα	Soft Tissue Sarcoma	1UR8	PDGFRα structure, target of Olaratumab
Omalizumab	IgE	Asthma, Chronic Spontaneous Urticaria	1F6A	Omalizumab Fab in complex with IgE
Opicinumab	IL-1β	Rheumatoid Arthritis	1I1B	IL-1β structure, target of Opicinumab
Oregovomab	CA125	Ovarian Cancer	1PC8	MAb-B43.13 (anti-CA125 antibody) Fab
Paliperidone palmitate	D2 receptor	Schizophrenia	6CM4	D2 receptor structure, target of Paliperidone
Panitumumab	EGFR	Colorectal Cancer	1YY8	Panitumumab Fab in complex with EGFR
Parsatuzumab	HER2	Gastric Cancer	1N8Z	Pertuzumab (similar to Parsatuzumab) Fab in complex with HER2
Pateclizumab	IL-8	Crohn's Disease	1ILQ	IL-8 structure, target of Pateclizumab
Pegaptanib	VEGF	Age-Related Macular Degeneration (AMD)	1TZS	Pegaptanib Fab in complex with VEGF
Pembrolizumab	PD-1	Various Cancers	5J89	Pembrolizumab in complex with PD-1
Peramivir	Neuraminidase	Influenza	3TI6	Peramivir in complex with neuraminidase

